thirdarcbio.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $197.75MM
Third Arc Bio'a biotech platform provides transformational therapies for solid tumors and Inflammation & Immunology diseases. They are able to create immune synapses to activate or inhibit T cells, providing medical companies with multifunctional antibodies to help treat immune system diseases. Third Arc Bio was founded in 2022 by Sanjaya Singh and is headquartered in Boston, MA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/16/2024 | Series A | $165MM | $xx.xx | $305.43MM | Abbvie Ventures, Abrdn, Bvf Partners, Cormorant Asset Management, Foresite Capital, Freepoint Capital Group, Goldman Sachs, Hillhouse Investment, Janus Henderson Investors, Logos Capital, Marshall Wace, Omega Funds, T. Rowe Price Associates, Vida Ventures | |
Price per Share
$xx.xx
Shares Outstanding
78,414,570
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Abbvie Ventures, Abrdn, Bvf Partners, Cormorant Asset Management, Foresite Capital, Freepoint Capital Group, Goldman Sachs, Hillhouse Investment, Janus Henderson Investors, Logos Capital, Marshall Wace, Omega Funds, T. Rowe Price Associates, Vida Ventures
|
||||||
01/01/2022 | Series Seed | $17.75MM | $xx.xx | $107.47MM | Omega Funds | |
Price per Share
$xx.xx
Shares Outstanding
17,750,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Omega Funds
|
||||||
01/01/2022 | Series Seed-2 | $15MM | $xx.xx | $107.47MM | Omega Funds | |
Price per Share
$xx.xx
Shares Outstanding
5,380,520
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Omega Funds
|